Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa
about
Efflux-mediated drug resistance in bacteria: an updateStructural basis for the inhibition of bacterial multidrug exportersDiverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in KunmingCumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.Efflux pumps as antimicrobial resistance mechanisms.Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strainBeyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesOverexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa.Pseudomonas aeruginosa: resistance to the maxModification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacinDevelopment and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patientsInteraction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosaInfluence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationMolecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.MexXY multidrug efflux system of Pseudomonas aeruginosa.Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.Extended-spectrum cephalosporinases: structure, detection and epidemiology.Current concepts in antibiotic-resistant gram-negative bacteria.Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosaBroad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.Pseudomonas Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature.Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosaExpression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles.Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiproleDesign of a large-scale femtoliter droplet array for single-cell analysis of drug-tolerant and drug-resistant bacteriaMolecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
P2860
Q24609407-B52687E3-04BD-4258-AD98-0D834B64E2FDQ27685149-0BEAF607-A600-4BDF-99A7-DB6F89F40B0BQ28602456-C3FA68D9-750F-4149-A957-B4BA31A4D7FAQ33267866-FE01131C-CA2D-45CE-A135-F5B689599803Q34003782-D21ABD84-B84B-41A0-931B-907D85466029Q34134628-3C9C5634-8C0A-4F36-A1AE-A405B9584BF3Q34266074-B10D57F5-FB4A-443E-8529-EF1B91B2456FQ34932869-DC0D7195-8B54-41FE-BAF5-C8010FF7A041Q35007624-3327DBF8-D883-415B-93B4-593CE3A57D49Q35066737-C721CE82-DDB3-4187-863F-66F8525BDABDQ35084559-5205C291-E0F2-471B-B735-EBEA9EA775B8Q35203279-DE432187-5BA3-4A5F-A16F-FE04AC19478BQ35482558-9992C604-B12E-4672-98E6-B9521FA2C9A1Q35598576-1F36522A-8141-46DC-B2A3-51547EC04482Q35758992-95D38BFF-821A-4A10-888C-F098704DF8F8Q35830489-86F805FA-5B0F-48E5-A598-8963C4BC93E7Q35879111-B2720170-EB71-4638-BCF9-63AB573881CFQ36095065-ED27F67F-006B-448E-AD27-675727DD81F2Q36295397-184763EB-B206-4241-BB6F-D6CEDFB9303CQ36313186-52C9F31D-3CB3-4219-9F6C-DFFE0E60CAC3Q36450695-4242176D-76A1-45A1-BC2F-95A9410CA363Q36482780-B5018975-A6CE-4DE4-AC2B-9861E40991C6Q36744840-D7E3B8A0-C19C-4F0B-AE6A-DF66EA7DF0FAQ36895772-1420833D-F51D-474D-9B3D-472C92B8EE55Q36960068-F316B169-FBBD-4BAB-8FBB-4223D89EE391Q37079350-4F7972E2-0EC4-4672-91A5-8808BFA9CD26Q37190771-FE2D16A8-B754-45B9-91A7-6BE1E8CAEC94Q37302114-A0BB4286-4665-4D39-B06F-0757CC51BD61Q37428703-23D6FA91-6B62-44B9-B40F-3922EDA5F642Q37544527-836495BE-8342-4D72-AA15-4169E5CBB36AQ37894832-60859678-346C-4088-9AD4-9C89922038A5Q40073768-238A063B-7E85-48C7-B33E-1238209891F8Q41183478-8285EFA7-0838-4293-B83B-7BCD5BDE29C5Q41839265-7020C5AF-4BAD-4CB7-AF72-4108130055D9Q41841534-63831EF0-D899-49E0-8007-7D3F08FFBB7FQ41843691-7F50365A-3EF0-4355-A9D3-B0101D22DAA9Q41901627-59B801EE-FD87-4763-89D9-F830D96E3CB9Q42089045-36D80D8A-10C8-46FA-AAE5-92EC4871FADDQ42256962-6BD364E8-B596-4CC5-B8C1-E733FB1CF015Q42612014-A1F65FF9-A57E-41E4-808D-8CA7B8CE4CD4
P2860
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Involvement of the MexXY-OprM ...... ains of Pseudomonas aeruginosa
@en
type
label
Involvement of the MexXY-OprM ...... ains of Pseudomonas aeruginosa
@en
prefLabel
Involvement of the MexXY-OprM ...... ains of Pseudomonas aeruginosa
@en
P2093
P2860
P1476
Involvement of the MexXY-OprM ...... ains of Pseudomonas aeruginosa
@en
P2093
Didier Hocquet
Farid El Garch
Ludovic Cabanne
Patrick Plésiat
P2860
P304
P356
10.1128/AAC.50.4.1347-1351.2006
P407
P577
2006-04-01T00:00:00Z